Immuron IMRN
NASDAQ IMRN
$0.95 -0.02 (-2.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Consolidated Net Income (2023 - 2024)

Updated

Immuron (IMRN) posted Consolidated Net Income of -$3.82 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Consolidated Net Income (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported Consolidated Net Income for 12 fiscal years.

  • Annual Consolidated Net Income has run from a low of -$5.22 million in FY2025 to a high of -$69,347 in FY2024 over five years.
  • Business Quant data shows IMRN's Consolidated Net Income at -$5.22 million in FY2025, -$69,347 in FY2024, -$2.07 million in FY2023 and -$1.98 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 210.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.62 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.51 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -10.50 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -237.00 Mn
10 Immuron 7.67 Mn -9.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.54 Mn
Sep 9, 2024 -46,208.27
Dec 31, 2023 -24,656.39
API Access

Immuron Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IMRN&period=max&api_key=YOUR_API_KEY